Short interest in MoonLake Immunotherapeutics (NASDAQ:MLTX) decreased during the last reporting period, falling from 7.94M to 7.77M. This put 30.1% of the company's publicly available shares short.

Short interest for MoonLake gives investors a sense of the degree to which investors are betting on the decline of MoonLake's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 254.91K shares traded per day, it would take 30.5 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.